For patients with amyotrophic lateral sclerosis (ALS), rapid eye movement (REM) inhibition via receipt of antidepressant medication is associated with a trend toward survival benefit, according to a study presented at the American Thoracic Society 2025 International Conference, held from May 18 to 21 in San Francisco.
This article was originally published on MedicalXpress.com